Callan Family Office LLC Acquires 550,711 Shares of Haleon PLC Sponsored ADR $HLN

Key Points

• Callan Family Office LLC increased its stake in Haleon PLC by 263.7% in Q2, acquiring an additional 550,711 shares and holding a total of 759,524 shares valued at approximately $7.88 million.
• Multiple analysts have revised their ratings on Haleon, with Barclays downgrading it from "overweight" to "equal weight," while Goldman Sachs upgraded it to a "buy" rating, reflecting a mixed sentiment among investors.
• Haleon declared a semi-annual dividend of $0.0555 per share, representing a boost from the previous dividend and indicating a payout ratio of 28.21%.

Callan Family Office LLC lifted its stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 263.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 759,524 shares of the company's stock after purchasing an additional 550,711 shares during the quarter. Callan Family Office LLC's holdings in Haleon were worth $7,876,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Brighton Jones LLC purchased a new position in Haleon in the 4th quarter worth about $187,000. Rhumbline Advisers grew its stake in shares of Haleon by 6.7% during the 1st quarter. Rhumbline Advisers now owns 57,527 shares of the company's stock valued at $592,000 after acquiring an additional 3,625 shares during the period. Merit Financial Group LLC grew its stake in shares of Haleon by 137.7% during the 1st quarter. Merit Financial Group LLC now owns 37,935 shares of the company's stock valued at $390,000 after acquiring an additional 21,975 shares during the period. Farther Finance Advisors LLC boosted its stake in Haleon by 8.8% in the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock worth $131,000 after purchasing an additional 1,041 shares during the period. Finally, Simplicity Wealth LLC boosted its stake in Haleon by 7.9% in the 1st quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock worth $159,000 after purchasing an additional 1,135 shares during the period. Hedge funds and other institutional investors own 6.67% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HLN. Barclays downgraded Haleon from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, September 16th. Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Weiss Ratings reiterated a "hold (c)" rating on shares of Haleon in a research note on Wednesday. Finally, The Goldman Sachs Group upgraded Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $12.33.

Haleon Trading Down 0.2%

Haleon stock opened at $9.02 on Friday. The stock has a 50-day moving average of $9.44 and a two-hundred day moving average of $10.03. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. Haleon PLC Sponsored ADR has a one year low of $8.71 and a one year high of $11.42. The stock has a market cap of $40.19 billion, a PE ratio of 23.13, a price-to-earnings-growth ratio of 2.67 and a beta of 0.20.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a $0.0555 dividend. This represents a yield of 190.0%. This is a boost from Haleon's previous semi-annual dividend of $0.05. The ex-dividend date was Friday, August 15th. Haleon's dividend payout ratio (DPR) is 28.21%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.